Related Experiment Video
Updated: Jul 30, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis]
I Harting1, J Sellner, U Meyding-Lamadé
1Abteilung Neuroradiologie, Neurologische Klinik, Universitätsklinikum Heidelberg. inga_harting@med.uni-heidelberg.de
Abstract:
Multiple sclerosis (MS) is the most common demyelinating inflammatory disease of the central nervous system (CNS), presenting with multifocal, disseminated inflammatory lesions referred to as plaques. Magnetic resonance imaging (MRI) typically depicts multiple, round to oval, circumscript lesions predominantly involving periventricular and subcortical white matter, brainstem and cerebellum. More recent investigations have demonstrated that the macroscopically visible plaques only present the tip of the iceberg: Already early in its course, MS causes neuroaxonal damage and diffusely involves the entire brain parenchyma including normal appearing white matter. These changes are reflected by strongly T1w hypointense lesions and atrophy of early onset, by reduction of the neuronal Marker N-acetylaspartate (NAA) on spectroscopy, by a decrease of the magnetization transfer ratio (MTR), by an increased in diffusibility and decreased anisotropy on diffusion-weighted imaging (DWI). MRI imaging is an important tool in the diagnosis of MS by revealing the characteristic spatial and temporal dissemination of the cerebral and spinal manifestations of this disease. Diagnostic criteria increase the diagnostic specificity and allow better differentiation from other diseases with multifocal white matter abnormalities.
Insights
Multiple sclerosis (MS) is a central nervous system (CNS) inflammatory disease. Advanced MRI techniques reveal early neuroaxonal damage beyond visible plaques, aiding diagnosis and differentiation.
Area of Science:
- Neurology
- Neuroimmunology
- Radiology
Context:
- Multiple sclerosis (MS) is the primary demyelinating inflammatory disease affecting the central nervous system (CNS).
- MS is characterized by multifocal inflammatory lesions (plaques) primarily in the white matter.
- Traditional Magnetic Resonance Imaging (MRI) visualizes these plaques but may underestimate disease extent.
Purpose:
- To highlight that visible MS plaques represent only a fraction of the disease's impact.
- To emphasize the early occurrence of neuroaxonal damage and diffuse brain involvement in MS.
- To showcase advanced MRI techniques and biomarkers reflecting sub-clinical changes.
Summary:
- MS involves widespread neuroaxonal damage and diffuse brain parenchyma infiltration, extending beyond macroscopic lesions.
- Early MS manifestations include T1-weighted hypointense lesions, early-onset atrophy, reduced N-acetylaspartate (NAA), decreased magnetization transfer ratio (MTR), and altered diffusion-weighted imaging (DWI) parameters.
- These imaging biomarkers indicate sub-clinical pathology in normal-appearing white matter.
Impact:
- MRI is crucial for diagnosing MS by demonstrating lesion dissemination in space and time.
- Advanced imaging metrics improve diagnostic specificity and differentiate MS from other white matter disorders.
- Understanding the full extent of MS pathology aids in developing more effective therapeutic strategies.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies IV: Magnetic Resonance Imaging
Multiple Sclerosis l: Introduction

